{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:22:06Z","timestamp":1774714926722,"version":"3.50.1"},"reference-count":83,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T00:00:00Z","timestamp":1282176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinically overt hypertrophic cardiomyopathy is the most common cause of sudden unexpected death in childhood and has significantly higher sudden death mortality in the 8\u2010 to 16\u2010year age range than in the 17\u2010 to 30\u2010year age range. A combination of electrocardiographic risk factors (a limb\u2010lead ECG voltage sum &gt;10\u2003mV) and\/or a septal wall thickness &gt;190% of upper limit of normal for age (<jats:italic>z<\/jats:italic>\u2010score\u2003&gt;\u20033.72) defines a paediatric high\u2010risk patient with great sensitivity. Syncope, blunted blood pressure response to exercise, non\u2010sustained ventricular tachycardia and a malignant family history are additional risk factors. Of the medical treatments used, only beta\u2010blocker therapy with lipophilic beta\u2010blockers (i.e. propranolol, metoprolol or bisoprolol) have been shown to significantly reduce risk of sudden death, with doses \u22656\u2003mg\/kg BW in propranolol equivalents giving around a tenfold reduction in risk. Disopyramide therapy is a very useful adjunct to beta\u2010blockers to improve prognosis in those patients that have dynamic outflow obstruction in spite of large doses of beta\u2010blocker, and its use in patients with hypertrophic cardiomyopathy is not associated with significant pro\u2010arrhythmia mortality. Calcium\u2010channel blockers increase the risk of heart failure\u2010associated death in hypertrophic cardiomyopathy (HCM) patients with severe generalized hypertrophy and should be avoided in such patients. Amiodarone does not protect against sudden death, and long\u2010term use in children usually has to be terminated because of side effects. Therapy with internal cardioverter defibrillator implantation has high paediatric morbidity, 27% incidence of inappropriate shocks, and does not absolutely protect against mortality but is indicated as secondary prevention or in very high\u2010risk patients.<\/jats:p>","DOI":"10.1111\/j.1472-8206.2010.00869.x","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T08:53:16Z","timestamp":1282207996000},"page":"637-652","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Hypertrophic cardiomyopathy in childhood and adolescence \u2013 strategies to prevent sudden death"],"prefix":"10.1111","volume":"24","author":[{"given":"Ingegerd","family":"\u00d6stman\u2010Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,19]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.47.562"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.62.2.218"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn122"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(87)80107-8"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.4.785"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.03.007"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00421-0"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009291"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.08.052"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.83.4.410"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.530303"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.621185"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl137"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.13.1593"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2009.061184"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp443"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(03)00479-2"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1997.tb00914.x"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.63.5.287"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.82.5.621"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.06.078"},{"issue":"1","key":"e_1_2_4_23_2","first-page":"60","article-title":"Frequency of diagnostic ECG\u2010abnormalities in children of parents with familial hypertrophic cardiomyopathy","volume":"17","author":"\u00d6stman\u2010Smith I.","year":"2007","journal-title":"Cardiol. Young"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.1.214"},{"key":"e_1_2_4_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2005.01539.x"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01003-2"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.79.4.331"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00094-7"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04005-8"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00838-6"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00493-8"},{"key":"e_1_2_4_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.59.10.971"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960130208"},{"key":"e_1_2_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(81)90535-X"},{"key":"e_1_2_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.051"},{"key":"e_1_2_4_36_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951105001824"},{"key":"e_1_2_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.071"},{"key":"e_1_2_4_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjr.0000238393.96975.32"},{"issue":"1","key":"e_1_2_4_39_2","first-page":"141","article-title":"Cardioprotection with beta\u2010adrenoceptor blockers. Does lipophilicity matter?","volume":"95","author":"Hjalmarson A.","year":"2000","journal-title":"Basic Res. Cardiol."},{"key":"e_1_2_4_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.7.742"},{"key":"e_1_2_4_41_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00144.2009"},{"key":"e_1_2_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.05.053"},{"key":"e_1_2_4_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.099416"},{"key":"e_1_2_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(78)90687-2"},{"key":"e_1_2_4_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/4.suppl_F.235"},{"issue":"53","key":"e_1_2_4_46_2","first-page":"36","article-title":"The effect of beta\u2010blocker dose on disease progression in children with hypertrophic cardiomyopathy","volume":"39","author":"\u00d6stman\u2010Smith I.","year":"2005","journal-title":"Scand. Cardiovasc. J."},{"key":"e_1_2_4_47_2","doi-asserted-by":"publisher","DOI":"10.2165\/11318030-000000000-00000"},{"key":"e_1_2_4_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2007.03046.x"},{"key":"e_1_2_4_49_2","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2007.9.1\/jchuffman"},{"issue":"1","key":"e_1_2_4_50_2","first-page":"40","article-title":"Effect of high\u2010dose beta\u2010blocker on exercise capacity in patients with hypertrophic cardiomyopathy","volume":"17","author":"Bratt E.\u2010L.","year":"2007","journal-title":"Cardiol. Young"},{"key":"e_1_2_4_51_2","unstructured":"BrattE.\u2010L. De\u2010Wahl GranelliA. \u00d6stman\u2010SmithI.Selective or non\u2010selective beta\u2010blockade \u2013 evaluation of exercise capacity in children and adolescents with hypertrophic cardiomyopathy. 5th World Congress of Paediatric Cardiology and Cardiac Surgery.http:\/\/www.pcccs2009.com."},{"key":"e_1_2_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90357-6"},{"key":"e_1_2_4_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.42.1.35"},{"key":"e_1_2_4_54_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.78.1_Supplement.239"},{"key":"e_1_2_4_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90589-7"},{"key":"e_1_2_4_56_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.64.3.437"},{"key":"e_1_2_4_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02026500"},{"issue":"1","key":"e_1_2_4_58_2","first-page":"10","article-title":"Effect of medical therapy in childhood hypertrophic cardiomyopathy with risk factors for heart\u2010failure related death","volume":"18","author":"\u00d6stman\u2010Smith I.","year":"2008","journal-title":"Cardiol. Young"},{"key":"e_1_2_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)90269-X"},{"key":"e_1_2_4_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00229-W"},{"key":"e_1_2_4_61_2","first-page":"33","article-title":"Combination of disopyramide and propranolol in hypertrophic cardiomyopathy","volume":"5","author":"Cokkinos D.V.","year":"1989","journal-title":"Can. J. Cardiol."},{"key":"e_1_2_4_62_2","first-page":"81","article-title":"Disopyramide as a negative inotrope in obstructive cardiomyopathy in children","volume":"7","author":"Duncan W.J.","year":"1991","journal-title":"Can. J. Cardiol."},{"key":"e_1_2_4_63_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.66.709"},{"key":"e_1_2_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)91199-5"},{"key":"e_1_2_4_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92158-E"},{"key":"e_1_2_4_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.012"},{"key":"e_1_2_4_67_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198611030-00003"},{"key":"e_1_2_4_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.53.4.412"},{"key":"e_1_2_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(89)90016-9"},{"key":"e_1_2_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90492-3"},{"key":"e_1_2_4_71_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.74.3.544"},{"key":"e_1_2_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90440-V"},{"key":"e_1_2_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00056-X"},{"key":"e_1_2_4_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2010.01764.x"},{"key":"e_1_2_4_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2003.00216.x"},{"key":"e_1_2_4_76_2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2000.36.11.601530"},{"key":"e_1_2_4_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(86)90674-5"},{"key":"e_1_2_4_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_2_4_79_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.22.2700"},{"key":"e_1_2_4_80_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000121426.43044.2B"},{"key":"e_1_2_4_81_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.4.405"},{"key":"e_1_2_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.01.054"},{"key":"e_1_2_4_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2009.02603.x"},{"key":"e_1_2_4_84_2","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200505060-00004"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2010.00869.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.2010.00869.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T02:46:08Z","timestamp":1697337968000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2010.00869.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,19]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1472-8206.2010.00869.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2010.00869.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,19]]},"assertion":[{"value":"2010-08-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}